Enhanced Osteosarcoma Immunotherapy via CaCO3 Nanoparticles: Remodeling Tumor Acidic and Immune Microenvironment for Photodynamic Therapy

Osteosarcoma (OS) is a “cold” tumor enriched in noninflammatory M2 phenotype tumor‐associated macrophages (TAMs), which limits the efficacy of immunotherapy. The acidic tumor microenvironment (TME), generated by factors such as excess hydrogen (H+) ions and high lactate levels, activates immunosuppressive cells, further promoting a suppressive tumor immune microenvironment (TIME). Therefore, a multitarget synergistic combination strategy that neutralizes the acidic TME and reprograms TAMs can be beneficial for OS therapy. Here, a calcium carbonate (CaCO3)/polydopamine (PDA)‐based nanosystem (A‐NPs@(SHK+Ce6)) is developed. CaCO3 nanoparticles are used to neutralize H+ ions and alleviate the suppressive TIME, and the loaded SHK not only synergizes with photodynamic therapy (PDT) but also inhibits lactate production, further reversing the acidic TME and repolarizing TAMs to consequently lead to enhanced PDT‐induced tumor suppression and comprehensive beneficial effects on antitumor immune responses. Importantly, A‐NPs@(SHK+Ce6), in combination with programmed cell death protein 1 (PD‐1) checkpoint blockade, shows a remarkable ability to eliminate distant tumors and promote long‐term immune memory function to protect against rechallenged tumors. This work presents a novel multiple‐component combination strategy that coregulates the acidic TME and TAM polarization to reprogram the TIME. A new multicombination strategy is designed that reprograms the immunosuppressive tumor microenvironment (TME) and enhances the effect of photodynamic therapy (PDT) for osteosarcoma (OS) treatment. The combination of A‐NPs@(SHK+Ce6) with programmed cell death protein 1 (PD‐1) demonstrates remarkable ability in eliminating distant tumors and promoting long‐term immune memory function, thereby protecting against tumor rechallenge.